Singapore markets open in 1 hour 43 minutes

QHSLab, Inc. (USAQ)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.06100.0000 (0.00%)
At close: 03:13PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0610
Open0.0610
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0610 - 0.0610
52-week range0.0160 - 0.2470
Volume173
Avg. volume15,917
Market cap623,145
Beta (5Y monthly)-0.18
PE ratio (TTM)N/A
EPS (TTM)-0.0500
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    QHSLab Announces Impressive 2023 Fiscal Year Results with Growing Revenues, Improved Gross Margins, and Substantial Reduction in Net Loss

    WEST PALM BEACH, FL, March 28, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, today reported its financial and operational results for the fiscal year ended December 31, 2023. The year was marked by robust revenue growth, significant improvements in gross margins, and a strategic focus on expanding produ

  • GlobeNewswire

    QHSLab Integrates Digital Medicine Assessments into Prominent Electronic Health Record (EHR) Company

    This integration allows QHSLab access to more than 160,000 providers that are the exact match for target providers. WEST PALM BEACH, FL, Jan. 30, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, is proud to announce the seamless integration of its digital medicine assessments with one of the nation’s top E

  • GlobeNewswire

    QHSLab, Inc. (USAQ) Reports Third Quarter Financial Results

    25% Y-O-Y Revenue Growth in Q3 2023 Compared to Q3 2022 and 51% Increase in Gross Profit. ●In Q3 2023, QHSLab generated $336,407 in revenues, reflecting a notable 25% year-over-year increase from the $269,323 reported in Q3 2022. ●Achieved a 55% gross margin over the nine months ending September 30, 2023, representing a 551-basis point growth in gross profit compared to the same period in 2022, and realized a remarkable 51% increase in gross profit, reaching $189,510 in the three months ended Se